keyword
https://read.qxmd.com/read/35092371/effects-of-a-self-monitoring-quality-of-life-intervention-in-outpatients-with-breast-cancer-a-preliminary-report-of-a-randomized-controlled-trial
#1
RANDOMIZED CONTROLLED TRIAL
Ayako Matsuda, Kenichi Inoue, Manami Momiyama, Kobayashi Kunihiko, Kaoru Kubota, Soerindra S R S Ramai, Maarten J Fischer, Judith R Kroep, Adrian A Kaptein, Kazue Yamaoka
OBJECTIVE: This preliminary report used data from a randomized controlled clinical trial to investigate the beneficial effects of a self-monitoring quality of life (SMQOL) intervention on communication, medical care and patient outcomes in Japanese women with breast cancer. METHODS: This study compared a SMQOL intervention group with a control group that received usual care after 4 months on self-efficacy aspects of patient-physician communication among outpatients with breast cancer in Japan using the Perceived Efficacy in Patient-Physician Interactions (PEPPI) questionnaire...
January 1, 2022: Asian Pacific Journal of Cancer Prevention: APJCP
https://read.qxmd.com/read/32561640/the-guanine-nucleotide-exchange-factor-vav3-participates-in-erbb4-mediated-cancer-cell-migration
#2
JOURNAL ARTICLE
Veera K Ojala, Anna M Knittle, Peppi Kirjalainen, Johannes A M Merilahti, Maarit Kortesoja, Denis Tvorogov, Katri Vaparanta, Shujun Lin, Jürgen Kast, Arto T Pulliainen, Kari J Kurppa, Klaus Elenius
ERBB4 is a member of the epidermal growth factor receptor (EGFR)/ERBB subfamily of receptor tyrosine kinases that regulates cellular processes including proliferation, migration, and survival. ERBB4 signaling is involved in embryogenesis and homeostasis of healthy adult tissues, but also in human pathologies such as cancer, neurological disorders, and cardiovascular diseases. Here, an MS-based analysis revealed the Vav guanine nucleotide exchange factor 3 (VAV3), an activator of Rho family GTPases, as a critical ERBB4-interacting protein in breast cancer cells...
August 14, 2020: Journal of Biological Chemistry
https://read.qxmd.com/read/31656242/validity-and-reliability-of-the-japanese-version-of-the-10-item-perceived-efficacy-in-patient-physician-interactions-peppi-10-scale-in-breast-cancer-outpatients
#3
JOURNAL ARTICLE
Ayako Matsuda, Kenichi Inoue, Manami Momiyama, Kunihiko Kobayashi, Kaoru Kubota, Takayoshi Ohkubo, Maarten J Fischer, Judith R Kroep, Soerindra S R S Ramai, Ad A Kaptein, Kazue Yamaoka
The 10-item Perceived Efficacy in Patient-Physician Interactions (PEPPI-10) questionnaire was used as an indirect measure of the patients' perception of the strength of their therapeutic connection with their physician. The English version of the PEPPI-10 could serve as a valuable research tool for analyzing the relationship between patient and physician. The incidence of breast cancer is amongst the highest in Japan, and Patient Reported Outcome is often used as an outcome measure for breast cancer. It is particularly important to establish a strong patient-physician interaction for patients with breast cancer, since these patients require long-term treatment...
2019: Tohoku Journal of Experimental Medicine
https://read.qxmd.com/read/31142511/the-pro-oncogenic-adaptor-cin85-acts-as-an-inhibitory-binding-partner-of-hypoxia-inducible-factor-prolyl-hydroxylase-2
#4
JOURNAL ARTICLE
Nina Kozlova, Daniela Mennerich, Anatoly Samoylenko, Elitsa Y Dimova, Peppi Koivunen, Ekaterina Biterova, Kati Richter, Antti Hassinen, Sakari Kellokumpu, Aki Manninen, Ilkka Miinalainen, Virpi Glumoff, Lloyd Ruddock, Lyudmyla Borysivna Drobot, Thomas Kietzmann
The EGFR adaptor protein, CIN85, has been shown to promote breast cancer malignancy and hypoxia-inducible factor (HIF) stability. However, the mechanisms underlying cancer promotion remain ill defined. Here we show that CIN85 is a novel binding partner of the main HIF-prolyl hydroxylase, PHD2, but not of PHD1 or PHD3. Mechanistically, the N-terminal SRC homology 3 domains of CIN85 interacted with the proline-arginine-rich region within the N-terminus of PHD2, thereby inhibiting PHD2 activity and HIF degradation...
August 15, 2019: Cancer Research
https://read.qxmd.com/read/29981745/cancer-associated-2-oxoglutarate-analogues-modify-histone-methylation-by-inhibiting-histone-lysine-demethylases
#5
JOURNAL ARTICLE
Tuomas Laukka, Matti Myllykoski, Ryan E Looper, Peppi Koivunen
Histone lysine demethylases (KDMs) are 2-oxoglutarate-dependent dioxygenases (2-OGDDs) that regulate gene expression by altering chromatin structure. Their dysregulation has been associated with many cancers. We set out to study the catalytic and inhibitory properties of human KDM4A, KDM4B, KDM5B, KDM6A and KDM6B, aiming in particular to reveal which of these enzymes are targeted by cancer-associated 2-oxoglutarate (2-OG) analogues. We used affinity-purified insect cell-produced enzymes and synthetic peptides with trimethylated lysines as substrates for the in vitro enzyme activity assays...
September 14, 2018: Journal of Molecular Biology
https://read.qxmd.com/read/29624633/disparities-in-the-survivorship-experience-among-latina-survivors-of-breast-cancer
#6
JOURNAL ARTICLE
Tinuke O Olagunju, Yihang Liu, Li-Jung Liang, James M Stomber, Jennifer J Griggs, Patricia A Ganz, Amardeep Thind, Rose C Maly
BACKGROUND: The authors investigated disparities in the survivorship experience among Latinas with breast cancer (BC) in comparison with non-Latinas. METHODS: A cross-sectional bilingual telephone survey was conducted among 212 Latina and non-Latina women within 10 to 24 months after a diagnosis of BC (AJCC TNM staging system stage 0-III) at 2 Los Angeles County public hospitals. Data were collected using the Preparing for Life as a (New) Survivor (PLANS) scale, Perceived Efficacy in Patient-Physician Interactions Questionnaire (PEPPI), Breast Cancer Prevention Trial (BCPT) Symptom Checklist, Satisfaction with Care and Information Scale, Consumer Assessment of Healthcare Providers and Systems (CAHPS) tool, Charlson Comorbidity Index adapted for patient self-report, and the 12-item Short Form Health Survey...
June 1, 2018: Cancer
https://read.qxmd.com/read/29545478/usp28-deficiency-promotes-breast-and-liver-carcinogenesis-as-well-as-tumor-angiogenesis-in-a-hif-independent-manner
#7
JOURNAL ARTICLE
Kati Richter, Teija Paakkola, Daniela Mennerich, Kateryna Kubaichuk, Anja Konzack, Heidi Ali-Kippari, Nina Kozlova, Peppi Koivunen, Kirsi-Maria Haapasaari, Arja Jukkola-Vuorinen, Hanna-Riikka Teppo, Elitsa Y Dimova, Risto Bloigu, Zoltan Szabo, Risto Kerkelä, Thomas Kietzmann
Recent studies suggest that the ubiquitin-specific protease USP28 plays an important role in cellular repair and tissue remodeling, which implies that it has a direct role in carcinogenesis. The carcinogenic potential of USP28 was investigated in a comprehensive manner using patients, animal models, and cell culture. The findings demonstrate that overexpression of USP28 correlates with a better survival in patients with invasive ductal breast carcinoma. Mouse xenograft experiments with USP28-deficient breast cancer cells also support this view...
June 2018: Molecular Cancer Research: MCR
https://read.qxmd.com/read/28656214/her2-regulates-cancer-stem-like-cell-phenotype-in-alk-translocated-nsclc
#8
JOURNAL ARTICLE
Tiia Honkanen, Emmi Wilenius, Peppi Koivunen, Jussi P Koivunen
We have previously shown that cancer stem-like cells (CSLCs) can mediate therapy resistance in ALK translocated lung cancers. HER2 has been linked to CSLCs in breast cancers and, therefore, we wanted to assess whether HER2 has a role in CSLCs in ALK translocated cancers. ALK translocated cell lines, H3122 and H2228, with variable sensitivity to ALK inhibition were used in the study. HER2 overexpression or knockdown was induced by retro- or lentiviral infections and cells were treated with pharmacological agents targeting HER2 and ALK signaling...
August 2017: International Journal of Oncology
https://read.qxmd.com/read/27368101/paracrine-induction-of-hif-by-glutamate-in-breast-cancer-egln1-senses-cysteine
#9
JOURNAL ARTICLE
Kimberly J Briggs, Peppi Koivunen, Shugeng Cao, Keriann M Backus, Benjamin A Olenchock, Hetalben Patel, Qing Zhang, Sabina Signoretti, Gary J Gerfen, Andrea L Richardson, Agnieszka K Witkiewicz, Benjamin F Cravatt, Jon Clardy, William G Kaelin
The HIF transcription factor promotes adaptation to hypoxia and stimulates the growth of certain cancers, including triple-negative breast cancer (TNBC). The HIFα subunit is usually prolyl-hydroxylated by EglN family members under normoxic conditions, causing its rapid degradation. We confirmed that TNBC cells secrete glutamate, which we found is both necessary and sufficient for the paracrine induction of HIF1α in such cells under normoxic conditions. Glutamate inhibits the xCT glutamate-cystine antiporter, leading to intracellular cysteine depletion...
June 30, 2016: Cell
https://read.qxmd.com/read/26560066/integrated-transcriptomic-proteomic-analysis-using-a-proteogenomic-workflow-refines-rat-genome-annotation
#10
JOURNAL ARTICLE
Dhirendra Kumar, Amit Kumar Yadav, Xinying Jia, Jason Mulvenna, Debasis Dash
Proteogenomic re-annotation and mRNA splicing information can lead to the discovery of various protein forms for eukaryotic model organisms like rat. However, detection of novel proteoforms using mass spectrometry proteomics data remains a formidable challenge. We developed EuGenoSuite, an open source multiple algorithmic proteomic search tool and utilized it in our in-house integrated transcriptomic-proteomic pipeline to facilitate automated proteogenomic analysis. Using four proteogenomic pipelines (integrated transcriptomic-proteomic, Peppy, Enosi, and ProteoAnnotator) on publicly available RNA-sequence and MS proteomics data, we discovered 363 novel peptides in rat brain microglia representing novel proteoforms for 249 gene loci in the rat genome...
January 2016: Molecular & Cellular Proteomics: MCP
https://read.qxmd.com/read/25238228/combining-targeted-drugs-to-overcome-and-prevent-resistance-of-solid-cancers-with-some-stem-like-cell-features
#11
JOURNAL ARTICLE
Elina Jokinen, Niina Laurila, Peppi Koivunen, Jussi P Koivunen
Treatment resistance significantly inhibits the efficiency of targeted cancer therapies in drug-sensitive genotypes. In the current work, we studied mechanisms for rapidly occurring, adaptive resistance in targeted therapy-sensitive lung, breast, and melanoma cancer cell lines. The results show that in ALK translocated lung cancer lines H3122 and H2228, cells with cancer stem-like cell features characterized by high expression of cancer stem cell markers and/or in vivo tumorigenesis can mediate adaptive resistance to oncogene ablative therapy...
October 15, 2014: Oncotarget
https://read.qxmd.com/read/23336272/the-prognostic-significance-and-value-of-cyclin-d1-cdk4-and-p16-in-human-breast-cancer
#12
JOURNAL ARTICLE
Emmi Peurala, Peppi Koivunen, Kirsi-Maria Haapasaari, Risto Bloigu, Arja Jukkola-Vuorinen
INTRODUCTION: Loss of the retinoblastoma protein tumor suppressor gene (RB) coding for a nuclear phosphoprotein that regulates the cell cycle is found in many human cancers and probably leads to disruption of the p16-cyclin D1-CDK4/6-RB pathway. Cyclin D1 is known to activate CDK4, which then phosphorylates the RB protein, leading to cell cycle progression. p16 inhibits CDK4, keeping RB hypophosphorylated and preventing cell cycle progression. The significance of these three markers, cyclin D1, CDK4 and p16, for breast cancer and carcinogenesis is nevertheless still controversial...
January 21, 2013: Breast Cancer Research: BCR
https://read.qxmd.com/read/23263740/adherence-to-adjuvant-hormone-therapy-in-low-income-women-with-breast-cancer-the-role-of-provider-patient-communication
#13
JOURNAL ARTICLE
Yihang Liu, Jennifer L Malin, Allison L Diamant, Amardeep Thind, Rose C Maly
To assess the impact of patient-provider communication on adherence to tamoxifen (TAM) and aromatase inhibitors (AIs) 36 months after breast cancer (BC) diagnosis in a low-income population of women. California statewide surveys were conducted among 921 low-income women with BC at 6, 18, and 36 months after BC diagnosis. A subset of 303 women with stage I-III BC who initiated hormone treatment after diagnosis was identified. Bivariate and multivariate logistic regression analyses were performed, and adjusted adherence rates were calculated...
February 2013: Breast Cancer Research and Treatment
https://read.qxmd.com/read/21877141/expressions-of-individual-phds-associate-with-good-prognostic-factors-and-increased-proliferation-in-breast-cancer-patients
#14
JOURNAL ARTICLE
Emmi Peurala, Peppi Koivunen, Risto Bloigu, Kirsi-Maria Haapasaari, Arja Jukkola-Vuorinen
Tumor hypoxia-inducible transcription factor (HIF) overexpression often associates with a poor prognosis. Stability of the HIF-α subunits is regulated by HIF prolyl 4-hydroxylases, PHD1-3. We assessed here immunohistochemical expression of PHD1-3 and HIF-1α and 2α in patients with invasive ductal breast carcinoma (n = 102) and correlated their expression levels with main clinical prognostic factors and survival. PHD1 expression correlated with high proliferation, and these tumors were mainly estrogen receptor-negative...
May 2012: Breast Cancer Research and Treatment
https://read.qxmd.com/read/20833474/the-daily-impact-of-pain-from-metastatic-breast-cancer-on-spousal-relationships-a-dyadic-electronic-diary-study
#15
JOURNAL ARTICLE
Hoda Badr, Jean-Philippe Laurenceau, Leslie Schart, Karen Basen-Engquist, Dennis Turk
Women with metastatic breast cancer (MBC) experience high levels of emotional distress and pain. Although individuals often rely on their intimate partners to provide physical and emotional support when they are in pain, the daily impact of pain on the spousal relationship in the context of advanced cancer is unclear. To understand how relationships are affected by pain, 57 MBC patients and their partners completed electronic diary assessments 6 times a day for 14 days. Patients and partners rated the patient's pain, their own mood (circumplex adjectives), the provision/receipt of social support, and the degree to which cancer interfered with their relationship...
December 2010: Pain
https://read.qxmd.com/read/16705484/mood-states-associated-with-transitory-physical-symptoms-among-breast-and-ovarian-cancer-survivors
#16
JOURNAL ARTICLE
Hoda Badr, Karen Basen-Engquist, Cindy L Carmack Taylor, Carl de Moor
This study used electronic diaries to examine patterns of mood and physical symptoms within and across days in two independent samples of cancer patients. Twenty-three breast cancer survivors (post-treatment) and 33 ovarian cancer survivors (on chemotherapy) recorded mood and physical symptoms 4 times daily for 7 consecutive days. A series of repeated-measures multilevel models using SAS Proc Mixed were calculated to estimate the degree to which physical symptoms (e.g., pain, fatigue, and nausea) were associated with participants' moods...
October 2006: Journal of Behavioral Medicine
1
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.